(Q46394125)

21 December 2017

title

Spironolactone prevents chronic kidney disease caused by ischemic acute kidney injury (English)

1 reference

21 December 2017

chronic renal insufficiency

main subject

1 reference

6

1 reference

21 December 2017

author name string

Jonatan Barrera-Chimal

1

1 reference

21 December 2017

Rosalba Pérez-Villalva

2

1 reference

21 December 2017

Roxana Rodríguez-Romo

3

1 reference

21 December 2017

Juan Reyna

4

1 reference

21 December 2017

Norma Uribe

5

1 reference

21 December 2017

Norma A Bobadilla

7

1 reference

21 December 2017

language of work or name

English

0 references

publication date

26 September 2012

1 reference

21 December 2017

published in

Kidney International

1 reference

21 December 2017

volume

83

1 reference

21 December 2017

issue

1

1 reference

21 December 2017

page(s)

93-103

1 reference

21 December 2017

The assessment, serial evaluation, and subsequent sequelae of acute kidney injury (ASSESS-AKI) study: design and methods

cites work

1 reference

https://api.crossref.org/works/10.1038%2FKI.2012.352

7 January 2021

Inflammatory cells in ischemic acute renal failure

1 reference

https://api.crossref.org/works/10.1038%2FKI.2012.352

7 January 2021

The nexus of acute kidney injury, chronic kidney disease, and World Kidney Day 2009.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2012.352

7 January 2021

Epidemiology of acute renal failure: a prospective, multicenter, community-based study. Madrid Acute Renal Failure Study Group

1 reference

https://api.crossref.org/works/10.1038%2FKI.2012.352

7 January 2021

Declining mortality in patients with acute renal failure, 1988 to 2002

1 reference

https://api.crossref.org/works/10.1038%2FKI.2012.352

7 January 2021

Acute renal failure: much more than a kidney disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.2012.352

7 January 2021

Cellular pathophysiology of ischemic acute kidney injury

1 reference

https://api.crossref.org/works/10.1038%2FKI.2012.352

7 January 2021

Epidemiology of acute kidney injury

1 reference

https://api.crossref.org/works/10.1038%2FKI.2012.352

7 January 2021

Early acute kidney injury predicts progressive renal dysfunction and higher mortality in severely burned adults

1 reference

https://api.crossref.org/works/10.1038%2FKI.2012.352

7 January 2021

Acute kidney injury: a springboard for progression in chronic kidney disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.2012.352

7 January 2021

Increased risk of death and de novo chronic kidney disease following reversible acute kidney injury

1 reference

https://api.crossref.org/works/10.1038%2FKI.2012.352

7 January 2021

The severity of acute kidney injury predicts progression to chronic kidney disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.2012.352

7 January 2021

Effects of spironolactone in an experimental model of chronic cyclosporine nephrotoxicity

1 reference

https://api.crossref.org/works/10.1038%2FKI.2012.352

7 January 2021

Renal ischemia-reperfusion injury is prevented by the mineralocorticoid receptor blocker spironolactone

1 reference

https://api.crossref.org/works/10.1038%2FKI.2012.352

7 January 2021

Adrenalectomy prevents renal ischemia-reperfusion injury

1 reference

https://api.crossref.org/works/10.1038%2FKI.2012.352

7 January 2021

New insights into the pathophysiology of cyclosporine nephrotoxicity: a role of aldosterone.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2012.352

7 January 2021

Therapeutic benefit of spironolactone in experimental chronic cyclosporine A nephrotoxicity.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2012.352

7 January 2021

Renocortical mRNA expression of vasoactive factors during spironolactone protective effect in chronic cyclosporine nephrotoxicity

1 reference

https://api.crossref.org/works/10.1038%2FKI.2012.352

7 January 2021

Mineralocorticoid receptor blockade confers renoprotection in preexisting chronic cyclosporine nephrotoxicity.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2012.352

7 January 2021

Recovery from ischemic acute kidney injury by spironolactone administration

1 reference

https://api.crossref.org/works/10.1038%2FKI.2012.352

7 January 2021

Smad2 protects against TGF-beta/Smad3-mediated renal fibrosis.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2012.352

7 January 2021

Acute kidney injury increases risk of ESRD among elderly

1 reference

https://api.crossref.org/works/10.1038%2FKI.2012.352

7 January 2021

Pathophysiology of ischemic acute kidney injury

1 reference

https://api.crossref.org/works/10.1038%2FKI.2012.352

7 January 2021

Long-term risk of mortality and other adverse outcomes after acute kidney injury: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1038%2FKI.2012.352

7 January 2021

Acute kidney injury episodes and chronic kidney disease risk in diabetes mellitus

1 reference

https://api.crossref.org/works/10.1038%2FKI.2012.352

7 January 2021

Hsp72 is an early and sensitive biomarker to detect acute kidney injury.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2012.352

7 January 2021

Kidney injury molecule-1 outperforms traditional biomarkers of kidney injury in preclinical biomarker qualification studies.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2012.352

7 January 2021

Early renal ischemia, with or without reperfusion, activates NFkappaB and increases TNF-alpha bioactivity in the kidney

1 reference

https://api.crossref.org/works/10.1038%2FKI.2012.352

7 January 2021

Role of TGF-β in chronic kidney disease: an integration of tubular, glomerular and vascular effects

1 reference

https://api.crossref.org/works/10.1038%2FKI.2012.352

7 January 2021

Chemokine expression in renal ischemia/reperfusion injury is most profound during the reparative phase

1 reference

https://api.crossref.org/works/10.1038%2FKI.2012.352

7 January 2021

Impaired endothelial proliferation and mesenchymal transition contribute to vascular rarefaction following acute kidney injury.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2012.352

7 January 2021

Acute and chronic microvascular alterations in a mouse model of ischemic acute kidney injury.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2012.352

7 January 2021

Differences in vascular reactivity in models of ischemic acute renal failure

1 reference

https://api.crossref.org/works/10.1038%2FKI.2012.352

7 January 2021

Acute kidney injury and CKD: chicken or egg?

1 reference

https://api.crossref.org/works/10.1038%2FKI.2012.352

7 January 2021

Epidermal growth factor receptor mediates the vascular dysfunction but not the remodeling induced by aldosterone/salt.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2012.352

7 January 2021

The endothelial mineralocorticoid receptor regulates vasoconstrictor tone and blood pressure

1 reference

https://api.crossref.org/works/10.1038%2FKI.2012.352

7 January 2021

Structural changes in small resistance arteries and left ventricular geometry in patients with primary and secondary hypertension

1 reference

https://api.crossref.org/works/10.1038%2FKI.2012.352

7 January 2021

Aldosterone impairs vascular reactivity by decreasing glucose-6-phosphate dehydrogenase activity

1 reference

https://api.crossref.org/works/10.1038%2FKI.2012.352

7 January 2021

Effects of aldosterone on the vasculature

1 reference

https://api.crossref.org/works/10.1038%2FKI.2012.352

7 January 2021

The role of tubulointerstitial inflammation in the progression of chronic renal failure.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2012.352

7 January 2021

Relationship between renal function and histological changes found in renal-biopsy specimens from patients with persistent glomerular nephritis

1 reference

https://api.crossref.org/works/10.1038%2FKI.2012.352

7 January 2021

The consequences of tubulo-interstitial changes for renal function in glomerulopathies. A morphometric and cytological analysis

1 reference

https://api.crossref.org/works/10.1038%2FKI.2012.352

7 January 2021

Tubular dilatation in the repair process of ischaemic tubular necrosis

1 reference

https://api.crossref.org/works/10.1038%2FKI.2012.352

7 January 2021

Epithelial cell cycle arrest in G2/M mediates kidney fibrosis after injury

1 reference

https://api.crossref.org/works/10.1038%2FKI.2012.352

7 January 2021

Fibrosis under arrest

1 reference

https://api.crossref.org/works/10.1038%2FKI.2012.352

7 January 2021

TGF-beta signal transduction in chronic kidney disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.2012.352

7 January 2021

Methylation determines fibroblast activation and fibrogenesis in the kidney

1 reference

https://api.crossref.org/works/10.1038%2FKI.2012.352

7 January 2021

An integrative view on the role of TGF-beta in the progressive tubular deletion associated with chronic kidney disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.2012.352

7 January 2021

Oxidative stress in renal dysfunction: mechanisms, clinical sequelae and therapeutic options.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2012.352

7 January 2021

Identifiers

DOI

10.1038/KI.2012.352

1 reference

21 December 2017

Dimensions Publication ID

1006436411

0 references

Fatcat ID

release_zgprdc5ggvhuzfhtadkpcptj4e

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/zgprdc5ggvhuzfhtadkpcptj4e

24 November 2022

mapped directly with Wikidata item

1 reference

21 December 2017